SEC 13F Intelligence

Managers / Q3 2019 · view latest →

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE

CIK 0001047859 · 500 CRESCENT COURT, SUITE 260, DALLAS, TX, 75201 · 2148713700

Reported Value
$130M
Q3 2019
Positions
21
Filings on Record
29
2019–present window
Filed
Nov 13, 2019
original filing

Summary

Paragon Associates & Paragon Associates II Joint Venture reported $130M in U.S.-listed holdings across 21 positions for Q3 2019.

Its largest position, Reata Pharmaceuticals, represents 15.2% of the portfolio.

Compared with Q2 2019, the fund opened 2 new positions and exited 6.

Portfolio Metrics

Turnover
+19.6%
vs prior filed quarter
Top-10 Concentration
+81.6%
share of reported value
Largest Position
+15.2%
Reata Pharmaceuticals
New / Exited
2 / 6
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $106MQ1 ’19Q2 ’19: $130MQ3 ’19: $130MQ4 ’19: $178MQ1 ’20: $93MQ1 ’20Q2 ’20: $91MQ3 ’20: $74MQ4 ’20: $65MQ1 ’21: $66MQ1 ’21Q2 ’21: $75MQ3 ’21: $88MQ4 ’21: $63MQ1 ’22: $54MQ1 ’22Q2 ’22: $51MQ3 ’22: $50MQ4 ’22: $54MQ1 ’23: $48MQ1 ’23Q2 ’23: $49MQ3 ’23: $31MQ4 ’23: $44MQ1 ’24: $56MQ1 ’24Q2 ’24: $41MQ3 ’24: $56MQ4 ’24: $43MQ1 ’25: $43MQ1 ’25Q2 ’25: $63MQ3 ’25: $56MQ4 ’25: $48MQ1 ’26: $74MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 96.6%Other: 1.9%US DOMESTIC: 1.5%
  • Common Stock · 96.6% · $125M
  • Other · 1.9% · $2M
  • US DOMESTIC · 1.5% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PTBPOTBELLY CORPNEW+153.2K153.2K+$668,000$668,000
NUVECTRA CORPNEW+200.0K200.0K+$272,000$272,000
ABBVABBVIE INCADDED+140.0K150.0K+$11M$11M
MHKMOHAWK INDS INCSOLD OUT−30.0K0−$4M$0
ELVANTHEM INCSOLD OUT−12.5K0−$4M$0
CFCF INDS HLDGS INCSOLD OUT−75.0K0−$4M$0
HRIHERC HLDGS INCSOLD OUT−30.0K0−$1M$0
DVNDEVON ENERGY CORP NEWSOLD OUT−45.0K0−$1M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

21 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1REATA PHARMACEUTICALS INCCL A15.18%$20M245.0K
2NEMNEWMONT GOLDCORP CORPORATIONhistory →COM10.24%$13M350.0K
3HUMHUMANA INChistory →COM9.86%$13M50.0K
4ABBVABBVIE INChistory →COM8.77%$11M150.0K
5OXYOCCIDENTAL PETE CORPhistory →COM8.58%$11M250.0K
6NVGSNAVIGATOR HOLDINGS LTDhistory →SHS8.43%$11M1.02M
7ABXBARRICK GOLD CORPORATIONhistory →COM6.68%$9M500.0K
8CICIGNA CORP NEWhistory →COM6.44%$8M55.0K
9DHXDHI GROUP INChistory →COM3.85%$5M1.30M
10WPMWHEATON PRECIOUS METALS CORPhistory →COM3.54%$5M175.0K
11PARRPAR PACIFIC HOLDINGS INChistory →COM NEW3.53%$5M200.0K
12EPSNEPSILON ENERGY LTDhistory →COM3.25%$4M1.08M
13AEMAGNICO EAGLE MINES LTDhistory →COM3.10%$4M75.0K
14IRIXIRIDEX CORPhistory →COM1.88%$2M1.32M
15COMMUNITY BANKERS TR CORPCOM1.66%$2M250.0K
16WPX ENERGY INCCOM1.64%$2M200.0K
17FORESTAR GROUP INCNOTE 3.750% 3/01.54%$2M2.00M
18AGIALAMOS GOLD INC NEWCOM CL A0.90%$1M200.0K
19PTBPOTBELLY CORPCOM0.52%$668,000153.2K
20NUVECTRA CORPCOM0.21%$272,000200.0K
21TUESDAY MORNING CORPCOM NEW0.20%$257,000163.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$74M14May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$48M12Feb 12, 202613F-HRchanges · EDGAR ↗
Q3 2025$56M12Nov 12, 202513F-HRchanges · EDGAR ↗
Q2 2025$63M15Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$43M13May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$43M12Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$56M16Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$41M11Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$56M16May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$44M15Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$31M10Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$49M13Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$48M11May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$54M17Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$50M12Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$51M11Aug 16, 202213F-HRchanges · EDGAR ↗
Q1 2022$54M7May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$63M10Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$88M17Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$75M16Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$66M11May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$65M10Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$74M8Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$91M10Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$93M13May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$178M19Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$130M21Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$130M25Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$106M30May 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.